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Abstract. An indirect enzyme-linked immunosorbent assay (ELISA) was developed for differentiation of animals infected with foot-and-mouth disease virus (FMDV) from vaccinated animals. The test was based on a highly pure and concentrated preparation of recombinant 3AB1 protein obtained by expression in a prokaryotic system, protein separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and electro elution. Experimental-and field-serum samples from naive, vaccinated, and infected cattle were tested for anti3AB1 antibody using the ELISA. A cutoff level was set at 35% of the maximum absorbance obtained with a positive control serum (FMDV-infected animal, 21 days postinfection [dpi]). This assay could detect antibodies from sera of animals experimentally infected by contact (n ϭ 118) with a sensitivity of 97.5%. The specificity was 100%, based on negative test results obtained on 109 sera from naive animals. Remarkably, all sera from animals vaccinated either once (n ϭ 102) or twice (n ϭ 30) were negative. In addition, this 3AB1-ELISA could detect seroconversion at 7 dpi in animals inoculated intradermolingually. This assay constitutes an important tool for the rapid detection of FMDV outbreaks in a vaccinated population. In addition, it presents a reliable, economical, and simple method for testing large numbers of serum samples.
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Foot-and-mouth disease (FMD) is one of the most devastating diseases of domestic ruminants because of the economic losses it generates (international trade embargoes), the decrease in productivity, and the highly expensive control programs. Foot-and-mouth disease affects all cloven-hoofed animals including cattle, sheep, pigs, goats, camellids, and more than 30 wildlife species. In countries where vaccination is practiced as a control measure, there is a need for serological methods that can effectively discriminate infected animals among vaccinated herds, to track the presence or absence of the virus in any given area.
The FMD virus (FMDV), causative agent of FMD, is an aftovirus that belongs to the Picornaviridae family. Seven FMDV types (A, O, C, SAT1, SAT2, SAT3, ASIA1) exist. The virus contains a single-stranded RNA that codes for structural and nonstructural proteins. Nonstructural proteins (Lb, 2C, 3D, 3A, 3AB 123 , 3ABC) are not present in vaccine formulations in large amounts and therefore provide a tool for differentiation of animals that have been exposed to live virus from noninfected (either vaccinated or susceptible unvaccinated) animals. Previous studies have shown that the nonstructural proteins 3AB 123 and 3ABC 3, 4, 12 are the most probable potential markers for differentiation of infected from vaccinated or naive animals. Several strategies have been applied to obtain antigen preparations of 3AB 123 and 3ABC, including their expression in Escherichia coli 1, 2, 5, 7 or Baculovirus, 6, 12 and the use of a synthetic peptide. 9 In addition, 1 group of workers have produced a recombinant form of 3AB1 associated with Glutathione S-transferase in a prokaryotic expression system, but the protein yield was very low in concentration. 10 The goal of this study was to produce a pure and highly concentrated preparation of recombinant 3AB1 for use in an FMDV-differential antibody enzyme-linked immunosorbent assay (ELISA).
The 3AB1 protein was obtained by expression of the recombinant plasmid pRSETA-hist-3AB1 in transformed E. coli BL21 bacteria after induction with 0.1 mM isopropyl-D-galactoside. Bacterial cultures were centrifuged and the pellet was resuspended in sample buffer (4% sodium dodecyl sulphate [SDS]/125 mM Tris-HCl [pH 6.8]/10% ␤-mercaptoethanol/10% glycerol/0.02% bromophenol blue). Samples were boiled and separated by electrophoresis in 12% SDS-polyacrylamide gels in a large-format electrophoresis apparatus. a Gels were stained with Coomassie blue to observe the protein bands. The 3AB1 recombinant protein band (31 kD) was identified by comparison with commercial molecular weight standards and was confirmed by immunoblotting using a specific antihistidine monoclonal antibody. b The polyacrylamide gel portion containing 3AB1 was excised and placed inside a dialysis membrane c with running buffer (25 mM Tris-HCl/250 mM glycine/0.1% SDS). Electroelution of the protein was carried out in a submerged horizontal electrophoresis apparatus a for 2 hours at 200 V in the same buffer. After this step, the sample inside the dialysis bag, containing electroeluted 3AB1 protein, was concentrated by inverse dialysis against solid sucrose.
The protein concentration of 3AB1 was measured using the Bradford test and by 3AB1-ELISA titration, obtaining a total amount of 30 mg of 3AB1 protein per liter of bacteria culture. Immunoblotting was performed by standard procedures to confirm the purity and concentration of the 3AB1 protein. 8 The purified 3AB1 was then diluted to about 1.5 mg/ml and stored at Ϫ20 C until further use.
For the standardization of the 3AB1-ELISA, the optimal dilutions of reagents were first determined by titration using a strong positive serum (FMDV-infected animal at 21 days postinfection [dpi]), a weak positive serum (FMDV-infected animal at 10 dpi), and a negative serum (FMDV free). The optimal amount of 3AB1 for discrimination of positive from negative sera was found to be 0.38 g/well. The effect of a blocking reagent was also evaluated by testing 2 concentrations of skim milk (3% and 6%) and 10% normal equine serum. The latter was selected because it most effectively reduced nonspecific binding in the assay. Even after blocking, some of the serum samples still exhibited nonspecific binding to E. coli proteins. Therefore, the effect of preadsorbing the sera with a sonicated E. coli crude extract from an overnight bacterial culture was assessed. Different dilutions of bacterial extract were tested (0.25, 0.125, 0.062, and 0.032 mg/ml), and a concentration of 0.125 mg/ml crude E. coli extract was found to be optimal to eliminate nonspecific binding of sera to E. coli proteins, without affecting the binding of positive sera (Fig. 1) . In addition, a well without protein was also incorporated to the 3AB1-ELISA to subtract the nonspecific absorbance resulting from the direct binding of serum antibodies to the plate. The 3AB1-ELISA was performed in 96-well Immulon-1 microplates. d Two columns were coated with purified 3AB1 protein (0.38 g/well) in coating buffer (carbonate/bicarbonate buffer, pH:9.6) and 1 column with buffer only. After blocking with ELISA buffer (phosphate-buffered saline [PBS], pH 7.4, 0.05% Tween 20, 10% normal equine serum), serum samples diluted 1:100 in ELISA buffer were preincubated with sonicated E. coli extract (0.125 mg protein/ml) for 1 hour at 37 C and added to the microplates in triplicates. Incubation was carried out for 1 hour at 37 C. Detection of antibodies bound to 3AB1 was performed by addition of peroxidase-labeled goat antibovine immunoglobulin G e diluted 1:1500 in ELISA buffer for 30 minutes at 37 C. The color reaction was developed using 0.5 mg/ml activated Ophenylenediamide dihydrochloride with 0.02% H 2 O 2 in phosphate citrate buffer (pH 5) and stopped after 15 minutes by adding 2N H 2 SO 4 . Absorbance was measured at 492 nm using an ELISA microplate reader. f Standard volumes of 50 l per well were used in each step of the reaction. After each step, the plate was washed 3 times with PBS-Tween. Serum from an FMDV-infected animal at 21 dpi was used as positive control. Serum samples from cattle experimentally infected by contact were used to establish the cutoff value and to evaluate the specificity and sensitivity of the 3AB1-ELISA. In 115 out of 118 samples from contact-exposed animals collected at 10-233 days after exposure to FMDV type O1 during vaccine potency tests, the absorbance values obtained were Ն35% of the value from the positive control (Fig. 2) . In contrast, all serum samples (n ϭ 109) from an FMD-free zone of Argentina (south of 42ЊS, Patagonia region) that were used to establish the specificity of the test yielded absorbance values below 35% of the value of the positive control. The same result was obtained with sera from vaccinated or revaccinated animals (n ϭ 132).
Thus, using 35% as cut off (with the Receiver Operating Characteristic Computer Analysis Program g ), the assay exhibited a specificity of 100% and a sensitivity of 97.5% (with a confidence interval of 100-94.5%) (Fig. 2) .
The kinetics of the detection of antibodies against recombinant 3AB1 during experimental infections by intradermolingual inoculation as measured by the 3AB1-ELISA was studied using sequential serum samples (5-233 dpi) from vaccinated animals, which were challenged with FMDV type O1 in the tongue. Seroconversion could be detected in 23% of the samples at 7 dpi, and 100% of the samples were positive at 10 dpi. Detection was possible in all animals until the last sampling day (day 233) (data not shown). When field sera (n ϭ 517) collected in 2002 from surveillance zones were tested using the 3AB1-ELISA, 24% (20-28%/95% confidence intervals) were positive. The same field samples were analyzed using 3 different commercial FMDV-diagnostic kits (CEDI, h UBI, i and CHEKIT j ) and yielded results similar to the 3AB1-ELISA (Nanni M, et al. unpublished data).
Diagnosis of FMDV infections is of critical importance in the control and eradication campaigns in endemic areas. Currently, Argentina is free of FMD and has a vaccination program. For Argentina and other countries that vaccinate, it is critical to have fast diagnostic methods that differentiate between infected and vaccinated animals. The assay described in this study provides such a tool and has the additional advantage of being locally produced. Epidemiological monitoring using this assay can allow Argentina to maintain its FMD-free status.
Protein expression systems in bacteria have been used widely in the large-scale production of exogenous proteins because of their simplicity and low cost. Large-scale bacterial cultures can be performed in any laboratory. However, the resulting protein preparations can present specificity problems when used in serological assays because sera can react with bacterial proteins, generating false-positive results. For these reasons, Shen et al. 9 developed an ELISA for the detection of antibodies against nonstructural FMDV proteins using a synthetic peptide from the 3B protein. Even though this system has the advantage of having a pure antigen with no exogenous contaminants, it is disadvantageous because of its high cost that hampers its wide use in developing countries. Similarly, affinity chromatography methods are too expensive to be used in the large-scale production of recombinant proteins when compared with the 3AB1 protein purification method developed in this study. Moreover, affinity chromatography is laborious and has low yield (about 20 mg of purified protein per 10 liters of bacterial culture). 11 The data from this study shows that a cutoff value of 35% (with respect to the optical density value of the positive control) yielded optimal sensitivity (97.5%) and specificity (100%). However, if sensitivity is fixed at 100%, the specificity decreases to 39% (26-52% confidence interval). It was observed that the 3 sera yielding false-negative results in the test at 35% cut off were obtained from animals in the early stages of infection (Յ10 days after contact). On the other hand, for animals inoculated intradermolingually, it was observed that at 10 dpi 100% were positive. Thus the suboptimal (97.5%) sensitivity appears to be because of the fact that some animals infected by contact may not yield a positive result when sampled during the early stages of infection.
The 24% positive rate among field samples from herds in FMDV outbreak-free zones could be because of viral circulation or the persistence of antibody titers for more than 1 year after the last known FMD outbreak. Given the facts that annual epidemiological surveys are a convenient method to monitor FMDV status and that antibodies against structural proteins persist for long periods in infected animals, serological testing of calves in the 6 months-1 year age group should be adequate to assess the status of viral circulation the year before sampling. This approach would have 2 advantages: first, at this age, colostrums-derived antibodies have already disappeared; second, overestimation caused by positive samples from previous years would be avoided.
In conclusion, the 3AB1 protein purification method and the 3AB1-ELISA developed in this study offer several benefits. These include 1) use of a well-known antigen expression system that is easy to implement in a large scale without handling the virus; 2) high yield of purified recombinant protein; and 3) a simple and fast diagnostic test that allows the testing of a large number of serum samples, with specificity and sensitivity comparable with established commercial kits. Of particular importance is the ability of the 3AB1-ELISA to differentiate between FMDV-infected animals and vaccinated or uninfected animals. This assay provides a valuable tool for use in eradication campaigns or for epidemiological monitoring in countries that want to achieve and maintain FMDV-free status.
